TransCode Therapeutics

RNAZ

Valor de mercado US$ 26,1 mi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Geode Capital Management Boston, Massachusetts	US$ 51 mil	–	–	–
2	2 Cahill Wealth Management Portage, Michigan	US$ 22,9 mil	–	–	–
3	3 HRT Financial New York	US$ 17 mil	–	–	–
4	4 Sheets Smith Wealth Management Winston-Salem, North Carolina	US$ 16,8 mil	–	–	–
5	5 State Street Boston, Massachusetts	US$ 14,1 mil	–	–	–
6	6 Susquehanna International Group Bala Cynwyd, Pennsylvania	US$ 14 mil	–	–	–
7	7 Two Sigma Investments New York	US$ 13,1 mil	–	–	–
8	8 Goldman Sachs New York	US$ 11,5 mil	–	–	–
9	9 Virtu Financial New York	US$ 11 mil	–	–	–
10	10 BlackRock New York	US$ 10,6 mil	–	–	–
11	11 Shay Capital New York	US$ 10,1 mil	–	–	–
12	12 Millennium Management New York	US$ 9 mil	–	–	–
13	13 Renaissance Technologies New York	US$ 9 mil	–	–	–
14	14 Triumph Capital Management Denver, Colorado	US$ 6,73 mil	–	–	–
15	15 Tower Research Capital (TRC) New York	US$ 4 mil	–	–	–
16	16 Morgan Stanley New York	US$ 784	–	–	–
17	17 UBS Group Zurich, Switzerland	US$ 777	–	–	–
18	18 Wells Fargo San Francisco, California	US$ 34	–	–	–
19	ACM 19 AIGH Capital Management Baltimore, Maryland	–	-US$ 1,42 mi	-2	Encerrada
20	20 K.J. Harrison & Partners Toronto, Ontario, Canada	–	-US$ 22 mil	–	–
21	21 Redmond Asset Management Henrico, Virginia	–	-US$ 100 mil	–	–
22	22 Vanguard Group Malvern, Pennsylvania	–	-US$ 220 mil	–	–
23	23 Worth Venture Partners Fort Lee, New Jersey	–	-US$ 357 mil	–	–